Page last updated: 2024-12-10
s 15261
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
S 15261: S15261 is the (L)-isomer; structure given in first source; for treatment of insulin resistance [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 3074609 |
| SCHEMBL ID | 501578 |
| MeSH ID | M0242748 |
Synonyms (29)
| Synonym |
|---|
| s 15261 |
| benzoic acid, 4-(2-((9h-fluoren-9-ylacetyl)amino)ethyl)-, 2-((2-methoxy-2-(3-(trifluoromethyl)phenyl)ethyl)amino)ethyl ester, ( |
| 2-[[2-methoxy-2-[3-(trifluoromethyl)phenyl]ethyl]amino]ethyl 4-[2-[[2-(9h-fluoren-9-yl)acetyl]amino]ethyl]benzoate |
| 3-(2-(2-(4-(2-(alpha-fluorenylacetylaminoethyl)benzoyloxy)ethylamino)-1-methoxylethyl))trifluoromethylbenzene |
| 159978-02-6 |
| unii-5dlu91775q |
| s15261 , |
| s-15261 |
| 5dlu91775q , |
| SCHEMBL501578 |
| benzoic acid, 4-(2-((9h-fluoren-9-ylacetyl)amino)ethyl)-, 2-((2-methoxy-2-(3-(trifluoromethyl)phenyl)ethyl)amino)ethyl ester, (-)- |
| 2-((2-methoxy-2-(3-(trifluoromethyl)phenyl)ethyl)amino)ethyl 4-(2-(2-(9h-fluoren-9-yl)acetamido)ethyl)benzoate |
| 2-(9h-fluoren-9-yl)-n-[2-(4-{[2-({2-methoxy-2-[3-(trifluoromethyl)phenyl]ethyl}amino)ethoxy]carbonyl}phenyl)ethyl]ethanimidic acid |
| DTXSID70936206 |
| Q27261881 |
| (+)-2-((2-methoxy-2-(3-(trifluoromethyl)phenyl)ethyl)amino)ethyl 4-(2-((2-(9h-fluoren-9-yl)acetyl)amino)ethyl)benzoate |
| benzoic acid, 4-(2-((9h-fluoren-9-ylacetyl)amino)ethyl)-, 2-((2-methoxy-2-(3-(trifluoromethyl)phenyl)ethyl)amino)ethyl ester, (+)- |
| s-15261, (+/-)- |
| s-15261, (+)- |
| WHJ73DP4AM , |
| benzoic acid, 4-(2-((9h-fluoren-9-ylacetyl)amino)ethyl)-, 2-((2-methoxy-2-(3-(trifluoromethyl)phenyl)ethyl)amino)ethyl ester |
| 2-((2-methoxy-2-(3-(trifluoromethyl)phenyl)ethyl)amino)ethyl 4-(2-((2-(9h-fluoren-9-yl)acetyl)amino)ethyl)benzoate |
| 212752-68-6 |
| benzoic acid, 4-(2-((2-(9h-fluoren-9-yl)acetyl)amino)ethyl)-, 2-((2-methoxy-2-(3-(trifluoromethyl)phenyl)ethyl)amino)ethyl ester, (+)- |
| benzoic acid, 4-(2-((2-(9h-fluoren-9-yl)acetyl)amino)ethyl)-, 2-((2-methoxy-2-(3-(trifluoromethyl)phenyl)ethyl)amino)ethyl ester |
| 34J8SAF62N , |
| 212752-69-7 |
| unii-whj73dp4am |
| unii-34j8saf62n |
Research Excerpts
Overview
S 15261 is a novel oral antihyperglycaemic drug with both insulin secretagogue and insulin-sensitizing effects.
| Excerpt | Reference | Relevance |
|---|---|---|
| "S 15261 is a novel oral antihyperglycaemic drug with both insulin secretagogue and insulin-sensitizing effects. " | ( Effects of S 15511, a therapeutic metabolite of the insulin-sensitizing agent S 15261, in the Zucker Diabetic Fatty rat. Pickavance, LC; Wilding, JP, 2007) | 2.01 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (8)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.02
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.02) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||